MedKoo Biosciences, Inc.
Tel:   +1-919-636-5577    Fax:   +1-919-980-4831    Email:   sales@medkoo.com
Search
Login Register
Search
MedKoo Cat#: 341555 | Name: Tilidine Hydrochloride

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Tilidine Hydrochloride has been discontinued.

Chemical Structure

Tilidine Hydrochloride
CAS#27107-79-5

Theoretical Analysis

MedKoo Cat#: 341555

Name: Tilidine Hydrochloride

CAS#: 27107-79-5

Chemical Formula: C17H24ClNO2

Exact Mass: 309.1496

Molecular Weight: 309.83

Elemental Analysis: C, 65.90; H, 7.81; Cl, 11.44; N, 4.52; O, 10.33

Price and Availability

This product was removed for the commercial reasons.
Related CAS #
No Data
Synonym
Tilidine Hydrochloride ; W 5759A; W-5759A; W5759A; Go 1261 C; GO-1261.
IUPAC/Chemical Name
3-Cyclohexene-1-carboxylic acid, 2-(dimethylamino)-1-phenyl-, ethyl ester, hydrochloride, (1R,2S)-rel-
InChi Key
MUWDJVKYGSDUSH-KPVRICSOSA-N
InChi Code
InChI=1S/C17H23NO2.ClH/c1-4-20-16(19)17(14-10-6-5-7-11-14)13-9-8-12-15(17)18(2)3;/h5-8,10-12,15H,4,9,13H2,1-3H3;1H/t15-,17+;/m0./s1
SMILES Code
O=C([C@]1(C2=CC=CC=C2)[C@@H](N(C)C)C=CCC1)OCC.[H]Cl
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 309.83 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Els C, Jackson TD, Kunyk D, Lappi VG, Sonnenberg B, Hagtvedt R, Sharma S, Kolahdooz F, Straube S. Adverse events associated with medium- and long-term use of opioids for chronic non-cancer pain: an overview of Cochrane Reviews. Cochrane Database Syst Rev. 2017 Oct 30;10:CD012509. doi: 10.1002/14651858.CD012509.pub2. Review. PubMed PMID: 29084357. 2: Wolfert C, Merbach M, Stammler G, Emrich O, Meid AD, Burhenne J, Blank A, Mikus G. [Erratum to: Management of chronic pain using extended release tilidine : Quality of life and implication of comedication on tilidine metabolism]. Schmerz. 2017 Oct;31(5):515. doi: 10.1007/s00482-017-0236-8. German. PubMed PMID: 28674828. 3: Wolfert C, Merbach M, Stammler G, Emrich O, Meid AD, Burhenne J, Blank A, Mikus G. [Management of chronic pain using extended release tilidine : Quality of life and implication of comedication on tilidine metabolism]. Schmerz. 2017 Oct;31(5):516-523. doi: 10.1007/s00482-017-0228-8. German. Erratum in: Schmerz. 2017 Jul 3;:. PubMed PMID: 28597312. 4: Feng XQ, Zhu LL, Zhou Q. Opioid analgesics-related pharmacokinetic drug interactions: from the perspectives of evidence based on randomized controlled trials and clinical risk management. J Pain Res. 2017 May 24;10:1225-1239. doi: 10.2147/JPR.S138698. eCollection 2017. Review. PubMed PMID: 28579821; PubMed Central PMCID: PMC5449157. 5: Sandhu A, Kao D, Mehler PS, Haigney MC, Krantz MJ. Cardiovascular disorders associated with naloxone monotherapy and in fixed-dose combination with opioids: Data from international safety surveillance. Int J Cardiol. 2016 Jun 1;212:360-3. doi: 10.1016/j.ijcard.2016.03.079. Epub 2016 Mar 24. PubMed PMID: 27060723. 6: Viaene J, Lanckmans K, Dejaegher B, Mangelings D, Vander Heyden Y. Comparison of a triple-quadrupole and a quadrupole time-of-flight mass analyzer to quantify 16 opioids in human plasma. J Pharm Biomed Anal. 2016 Aug 5;127:49-59. doi: 10.1016/j.jpba.2015.12.055. Epub 2016 Jan 3. PubMed PMID: 26795707. 7: Yayan J, Rasche K. Treatment Options for Central Sleep Apnea: Comparison of Ventilator, Oxygen, and Drug Therapies. Adv Exp Med Biol. 2016;905:79-86. doi: 10.1007/5584_2015_183. PubMed PMID: 26747067. 8: Niemier K, Schindler M, Volk T, Baum K, Wolf B, Eberitsch J, Seidel W. [Efficacy of epidural steroid injections for chronic lumbar pain syndromes without neurological deficits. A randomized, double blind study as part of a multimodal treatment concept]. Schmerz. 2015 Jul;29(3):300-7. doi: 10.1007/s00482-015-0020-6. German. PubMed PMID: 26099752. 9: Eichbaum C, Mathes K, Burhenne J, Markert C, Blank A, Mikus G. Pre-systemic elimination of tilidine: localization and consequences for the formation of the active metabolite nortilidine. Basic Clin Pharmacol Toxicol. 2015 Feb;116(2):129-33. doi: 10.1111/bcpt.12328. Epub 2014 Oct 7. PubMed PMID: 25223231. 10: Krüger R, Meißner W, Zimmer A. [Misuse of opioid analgesics. An internet analysis]. Schmerz. 2014 Oct;28(5):473-82. doi: 10.1007/s00482-014-1466-7. Review. German. PubMed PMID: 25106826. 11: Gogol M, Hartmann H, Wustmann S, Simm A. Influence of central nervous system-acting drugs on results of cognitive testing in geriatric inpatients. Z Gerontol Geriatr. 2014 Jun;47(4):279-84. doi: 10.1007/s00391-014-0654-5. PubMed PMID: 25088385. 12: Poetzsch M, Baumgartner MR, Steuer AE, Kraemer T. Segmental hair analysis for differentiation of tilidine intake from external contamination using LC-ESI-MS/MS and MALDI-MS/MS imaging. Drug Test Anal. 2015 Feb;7(2):143-9. doi: 10.1002/dta.1674. Epub 2014 Jun 16. PubMed PMID: 24935086. 13: Dong J, Liu S, Zhang H, Hua Q, Zhao X, Miao L. Determination of naloxone-3-glucuronide in human plasma and urine by HILIC-MS/MS. J Chromatogr B Analyt Technol Biomed Life Sci. 2013 Dec 30;942-943:83-7. doi: 10.1016/j.jchromb.2013.09.036. Epub 2013 Oct 23. PubMed PMID: 24216276. 14: Radbruch L, Glaeske G, Grond S, Münchberg F, Scherbaum N, Storz E, Tholen K, Zagermann-Muncke P, Zieglgänsberger W, Hoffmann-Menzel H, Greve H, Cremer-Schaeffer P. Topical review on the abuse and misuse potential of tramadol and tilidine in Germany. Subst Abus. 2013;34(3):313-20. doi: 10.1080/08897077.2012.735216. Review. PubMed PMID: 23844964. 15: Vinetti M, Duprez T, Hantson P. Severe postoperative hyperthermic syndrome after addition of tilidine/naloxone to duloxetine therapy. Clin Toxicol (Phila). 2013 Jul;51(6):516-7. doi: 10.3109/15563650.2013.808748. Epub 2013 Jun 14. PubMed PMID: 23768028. 16: Scharnagel R, Kaiser U, Schütze A, Heineck R, Gossrau G, Sabatowski R. [Chronic non-cancer-related pain. Long-term treatment with rapid-release and short-acting opioids in the context of misuse and dependency]. Schmerz. 2013 Feb;27(1):7-19. doi: 10.1007/s00482-012-1278-6. Review. German. PubMed PMID: 23340881. 17: van der Hooft JJ, de Vos RC, Mihaleva V, Bino RJ, Ridder L, de Roo N, Jacobs DM, van Duynhoven JP, Vervoort J. Structural elucidation and quantification of phenolic conjugates present in human urine after tea intake. Anal Chem. 2012 Aug 21;84(16):7263-71. doi: 10.1021/ac3017339. Epub 2012 Aug 2. PubMed PMID: 22827565. 18: Maier C, Leclerc-Springer J. [Life-threatening fentanyl and propofol addiction: interview with a survivor]. Anaesthesist. 2012 Jul;61(7):601-7. doi: 10.1007/s00101-012-2036-y. German. PubMed PMID: 22714402. 19: Grün B, Merkel U, Riedel KD, Weiss J, Mikus G. Contribution of CYP2C19 and CYP3A4 to the formation of the active nortilidine from the prodrug tilidine. Br J Clin Pharmacol. 2012 Nov;74(5):854-63. doi: 10.1111/j.1365-2125.2012.04261.x. PubMed PMID: 22381043; PubMed Central PMCID: PMC3495150. 20: Wustrow I, Riedel KD, Mikus G, Weiss J. In vitro identification of the cytochrome P450 isozymes involved in the N-demethylation of the active opioid metabolite nortilidine to bisnortilidine. Naunyn Schmiedebergs Arch Pharmacol. 2012 Jun;385(6):633-9. doi: 10.1007/s00210-012-0737-z. Epub 2012 Feb 15. PubMed PMID: 22349139.